102 related articles for article (PubMed ID: 15995635)
1. Hierarchy of treatment variables affecting outcome of 131I therapy in thyroid cancer patients with lung metastases.
Kozak OV; Sukach GG; Korchinskaya OI; Trembach AM; Turicina VL; Voit NU
Exp Oncol; 2005 Jun; 27(2):150-5. PubMed ID: 15995635
[TBL] [Abstract][Full Text] [Related]
2. First treatment activity and outcome of radioiodine therapy in thyroid cancer patients with metastases in lymph nodes: mathematical correlation and clinical implications.
Kozak OV; Muzichenko LV; Trembach AM; Voit NU; Turicina VV
Exp Oncol; 2006 Mar; 28(1):75-9. PubMed ID: 16614713
[TBL] [Abstract][Full Text] [Related]
3. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
[TBL] [Abstract][Full Text] [Related]
4. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
[TBL] [Abstract][Full Text] [Related]
5. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
[TBL] [Abstract][Full Text] [Related]
6. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
[TBL] [Abstract][Full Text] [Related]
7. [Results of radioiodine therapy in patients with pulmonary metastases of differentiated thyroid cancer].
Ono Y; Yamamoto Y; Nishiyama Y; Nakano S; Takahashi K; Kawasaki Y; Satoh K; Ohkawa M; Tanabe M
Kaku Igaku; 2000 Nov; 37(6):661-70. PubMed ID: 11193452
[TBL] [Abstract][Full Text] [Related]
8. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
9. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
10. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
11. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
12. The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I.
Verburg FA; Verkooijen RB; Stokkel MP; van Isselt JW
Nuklearmedizin; 2009; 48(4):138-42; quiz N19-20. PubMed ID: 19384451
[TBL] [Abstract][Full Text] [Related]
13. [Lungs absorbed dose in radioiodine therapy of differentiated thyroid carcinoma with diffuse pulmonary metastases].
Liu B; Zeng Y; Wang J; Zhao Z; Mu D; Kuang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):851-4. PubMed ID: 20842858
[TBL] [Abstract][Full Text] [Related]
14. Lung metastases from differentiated thyroid carcinoma. A 40 years' experience.
Ronga G; Filesi M; Montesano T; Di Nicola AD; Pace C; Travascio L; Ventroni G; Antonaci A; Vestri AR
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):12-9. PubMed ID: 15194999
[TBL] [Abstract][Full Text] [Related]
15. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
16. [Determining the activities of 131I with dose-rate constraint method for the treatment of differentiated thyroid carcinoma with diffuse pulmonary metastases].
Liu B; Zeng Y; Wang JT; Zhao Z; Mu D; Kuang AR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):513-7. PubMed ID: 20629335
[TBL] [Abstract][Full Text] [Related]
17. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
[TBL] [Abstract][Full Text] [Related]
18. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
[TBL] [Abstract][Full Text] [Related]
19. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
20. [Long-term results of iodine radioisotope therapy for lung metastasis of thyroid cancer].
Tsyb AF; Drozdovskiĭ BI; Proshin VV
Vopr Onkol; 1996; 42(3):73-5. PubMed ID: 8801748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
